Professor Martin Steinhoff is a Professor and Chairman of the Department of Dermatology at Hamad Medical Corporation (HMC), where he also serves as the Director of the HMC Translational Research Institute and Associate Residency Program Director. He is a Full Professor at Weill Cornell Medicine in New York and Qatar, Hamad Bin Khalifa University, and Qatar University. He has also been an Adjunct Professor at the University of California, San Diego, the University of California, Davis, and the University College, Dublin, Ireland.

Professor Steinhoff studied Medicine and Human Biology in Germany, where he received his MD (magna cum laude) and PhD (summa cum laude) from the University of Marburg. He received his Dermatology training at the University in Muenster, Germany, and Post-doc training at the University of California San Francisco, United States. He finished with a first author Nature Medicine publication in 2000 describing a new mechanism of neuro-inflammation and pruritus.

Professor Steinhoff’s research interests are neuroimmunology, molecular immunology, and precision medicine. His group described various new mechanisms and characterized novel neuroimmune circuits in chronic skin diseases such as rosacea, atopic dermatitis, and pruritus/prurigo, leading to the development of new medications.

Professor Steinhoff has published approximately 300 peer-reviewed articles (H-index: 93, with a total impact factor exceeding 1700) and has contributed to more than 40 book chapters and 1,000 abstracts. He has been invited to give over 900 lectures and holds numerous patents.

His research has been funded with more than 60 million euros to date. In 2023, his group received the only Precision Medicine award from the Qatar Foundation, using omics technologies, genetics, and immunology tools to improve atopic dermatitis through a personalized medicine approach. A psoriasis grant investigating the connection between psoriasis and diabetes was recently funded with 1 million dollars.

Finally, Professor Steinhoff has served as the principal investigator on more than 25 clinical trials and co-principal investigator on more than 50 clinical trials. He has received several prestigious international research awards and is an honorary member of various dermatology societies.